Article Versions Notes

Venuti F, Gaviraghi A, De Nicolò A, Stroffolini G, Longo BM, Di Vincenzo A, Ranzani FA, Quaranta M, Romano F, Catellani E, et al. Real-Life Experience of Continuously Infused Ceftolozane/Tazobactam in Patients with Bronchiectasis and Multidrug-Resistant Pseudomonas aeruginosa Infection in the Outpatient Setting. Antibiotics. 2023; 12(7):1214. https://doi.org/10.3390/antibiotics12071214

Venuti, Francesco, Alberto Gaviraghi, Amedeo De Nicolò, Giacomo Stroffolini, Bianca Maria Longo, Alessia Di Vincenzo, Fabio Antonino Ranzani, Matilde Quaranta, Francesca Romano, Eleonora Catellani, and et al. 2023. "Real-Life Experience of Continuously Infused Ceftolozane/Tazobactam in Patients with Bronchiectasis and Multidrug-Resistant Pseudomonas aeruginosa Infection in the Outpatient Setting" Antibiotics 12, no. 7: 1214. https://doi.org/10.3390/antibiotics12071214

Venuti, F., Gaviraghi, A., De Nicolò, A., Stroffolini, G., Longo, B. M., Di Vincenzo, A., Ranzani, F. A., Quaranta, M., Romano, F., Catellani, E., Marchiaro, C., Cinnirella, G., D’Avolio, A., Bonora, S., & Calcagno, A. (2023). Real-Life Experience of Continuously Infused Ceftolozane/Tazobactam in Patients with Bronchiectasis and Multidrug-Resistant Pseudomonas aeruginosa Infection in the Outpatient Setting. Antibiotics, 12(7), 1214. https://doi.org/10.3390/antibiotics12071214